RMTI (RMTI) revenue breakdown
By product, Concentrate Products is the largest at 100% of fiscal 2024 revenue, growing 11% a year over 5 years.
By region, U.S. is the largest at 87% of fiscal 2025 revenue; Rest of World grew fastest, 3% a year over 8 years.
Revenue by product
Fiscal years, as RMTI reports them in its 10-K filings; fiscal 2024 total $101M.
| Products | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Share |
|---|---|---|---|---|---|---|---|---|
| Concentrate Products | — | $61M | $61M | $61M | $72M | $81M | $101M | 100% |
| Drug Revenues | — | $545,000 | $1M | $1M | $1M | $2M | $46,000 | 0% |
| Product | $61M | — | — | — | — | — | — | — |
| License | $2M | — | — | — | — | — | — | — |
Revenue by region
Fiscal years, as RMTI reports them in its 10-K filings; fiscal 2025 total $69M.
| Regions | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| U.S. | $50M | $54M | $55M | $57M | $55M | $66M | $74M | $92M | $60M | 87% |
| Rest of World | $7M | $9M | $7M | $6M | $7M | $7M | $9M | $9M | $9M | 13% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for RMTI.
Open RMTI in InvestinglyQuestions
Where does RMTI make its money?
In fiscal 2024, by product: Concentrate Products $101M, Drug Revenues $46,000.
From RMTI's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.